Live feed08:47:08·9mANALYSTRatingvia QuantisnowLadenburg Thalmann resumed coverage on Compass Therapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.CMPX· Compass Therapeutics Inc.Health CareOriginal source